Misztak, Paulina

Oxidative stress markers in affective disorders

Siwek, M., Sowa-Kućma, M., Dudek, D., Styczeń, K., Szewczyk, B., Kotarska, K., Misztak, P., Pilc, A., Wolak, M., & Nowak, G. (2013) · Pharmacological Reports

Tryptophan and brain disordersTreatment of Major Depression

Cited by 142

Glutamate-Mediated Excitotoxicity in the Pathogenesis and Treatment of Neurodevelopmental and Adult Mental Disorders

Nicosia, N., Giovenzana, M., Misztak, P., Mingardi, J., & Musazzi, L. (2024) · International Journal of Molecular Sciences

Neuroscience and Neuropharmacology ResearchGenetics and Neurodevelopmental Disorders

Cited by 135

Are there differences in lipid peroxidation and immune biomarkers between major depression and bipolar disorder: Effects of melancholia, atypical depression, severity of illness, episode number, suicidal ideation and prior suicide attempts

Sowa-Kućma, M., Styczeń, K., Siwek, M., Misztak, P., Nowak, R. J., Dudek, D., Rybakowski, J. K., Nowak, G., & Maes, M. (2018) · Progress in Neuro-Psychopharmacology and Biological Psychiatry

Tryptophan and brain disordersBipolar Disorder and Treatment

Cited by 104

Vortioxetine: A review of the pharmacology and clinical profile of the novel antidepressant

Sowa-Kućma, M., Pańczyszyn-Trzewik, P., Misztak, P., Jaeschke, R. R., Sendek, K., Styczeń, K., Datka, W., & Koperny, M. (2017) · Pharmacological Reports

Treatment of Major DepressionNeurotransmitter Receptor Influence on Behavior

Cited by 86

Associations of serum cytokine receptor levels with melancholia, staging of illness, depressive and manic phases, and severity of depression in bipolar disorder.

Siwek, M., Sowa-Kućma, M., Styczeń, K., Misztak, P., Nowak, R. J., Szewczyk, B., Dudek, D., Rybakowski, J. K., Nowak, G., & Maes, M. (2017) · Molecular Neurobiology

Bipolar Disorder and TreatmentTryptophan and brain disorders

Cited by 65